1. Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
   Shigenori Ei et al, 2023, Gut and Liver CrossRef
2. IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study
   Tao Lv et al, 2019, Investigational New Drugs CrossRef